Interventional effect of bone peptide on mandibular osteoporosis induced by retinoic acid in rats

Jun-fang Zhang,Yong-xiang Xia,Jun-ling Cao

DOI: https://doi.org/10.3321/j.issn:1673-8225.2006.39.030

2006-01-01

Abstract:AIM: To investigate the effect of bone peptide on rats with mandibular osteoporosis induced by retinoic acid. METHODS: The study was carried out in the Animal Laboratory and Bone and Cartilage Biochemistry Laboratory of Institute of Endemic Disease, Xi'an Jiao Tong University between March and April 2001. ①Thirty-six female SD rats were randomly allocated into control group (n=11) and model group (n=25). The rats in model group were treated with 85 mg/kg per day of retinoic acid with gastric perfusion for 15 days to induce mandibular osteoporosis. After 15-day perfusion, 5 animals of each group were respectively executed to observe the pathomorphology and histomorphometry of the rat mandibles. After mandibular osteoporosis model was established, the experiment entered into treatment stage. ②The rats were divided into four groups: 6 remaining rats in above-mentioned control group were regarded as normal control group, and 20 remaining rats in above-mentioned model group were divided into three groups, osteoporosis group (n=6), bone peptide treatment group (n=8) and estrogen treatment group (n=6). The rats in normal control group and osteoporosis group were fed on normal diet as usual; bone peptide treatment group, fed on bone peptide injection (the basis of injection was bone morphogenetic protein, various growth factor and various microelement, produced by Kangning Pharmacy Factory of Chongqing, Guotai Pharmacy Limited Incorporated Company) 0.08 mg/kg per day by peritoneal injection; estrogen treatment group, fed on betaestradiol (produced by Jinyao Aminophenol Company of Tianjin), 50 μg per rat, three times per week by peritoneal injection. Sacrificed after treatment for 30 days, mandibular molar part was removed for hematoxylin and eosin pathological section preparation. Totally 5 rats were randomly selected to measure histomorphometry, and indices included cancellous bone area/total bone area, trabecular width and trabecular separation, etc. RESULTS: Totally 36 rats were involved in the result analysis. ①The results of mandibular pathomorphology observation in each group: In model duplication stage, the mandibular trabecular bone of the rats in model group was thin with a large medullary cavity of bone and the number and activity of osteoclast was increased, whereas the trabecular bone of the rats in control group was full. Thirty days after treatment with bone peptide and estrogen, compared with osteoporosis group, the number and the width of trabecular bone of two treatment group was increased, the separation of trabecular bone was decreased, the large medullary cavity of bone became smaller. ②The results of mandibular histomorphometry in each group: In model duplication stage, compared with control group, the trabecular width of the model group rats was obviously smaller (P < 0.05), whereas the trabecular separation was significantly bigger (P < 0.05). After treatment for 30 days, the trabecular width of the rest three groups was significantly increased (P < 0.05), whereas the trabecular separation of the three groups was significantly decreased (P < 0.05) as compared with osteoporosis group. CONCLUSION: Bone peptide can effectively improve the structure of mandible, slow down bone resorption, promote bone formation and provide beneficial effects for mandibular osteoporosis.